Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Zacks News
Here's Why You Should Retain Interpublic (IPG) Stock for Now
by Zacks Equity Research
Solid shareholder-friendly activities and strong liquidity boost Interpublic (IPG). However, seasonality in business is a bane.
Here's Why You Should Hold FLEETCOR (FLT) in Your Portfolio
by Zacks Equity Research
The recent acquisition of Levarti strengthens FLEETCOR's (FLT) airline-lodging business that reserves multiple hotel rooms for global airlines' crews and disrupted passengers every year.
Paychex (PAYX) Stock Up 12.3% in a Year: What's Behind It?
by Zacks Equity Research
Paychex (PAYX) stock has been benefiting from consecutive better-than-expected top and bottom-line performance, shareholder-friendly moves and encouraging guidance.
What Is a Safe Stock?
by Sejuti Banerjea
Inflation is atop everyone's mind as the Fed readies for a 50 (or 75, or...?) basis-point increase in the Fed funds interest rate.
Here's Why You Should Retain Robert Half (RHI) Stock For Now
by Zacks Equity Research
Robert Half (RHI) benefits from a solid balance sheet and Protiviti.
Reasons to Retain FactSet (FDS) Stock in Your Portfolio
by Zacks Equity Research
The recent acquisition of CUSIP Global Services is expected to significantly boost FactSet's (FCN) open data strategy and expand its position in the global capital markets.
Here's Why You Should Retain Broadridge (BR) in Portfolio Now
by Zacks Equity Research
Broadridge (BR) rides on strategic takeovers and a solid business model. However, balance-sheet weakness is a headwind.
6 Reasons Why Investors Should Buy Genpact (G) Stock Now
by Zacks Equity Research
Acquisitions have helped Genpact (G) expand its portfolio and gain new domain expertise. Artificial Intelligence offers the company solid growth opportunities.
4 Reasons to Buy Cross Country Healthcare (CCRN) Stock Now
by Zacks Equity Research
Cross Country Healthcare (CCRN) is currently benefiting from its investments in headcount and technology.
Cross Country Healthcare (CCRN) Stock Moves -0.65%: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed the most recent trading day at $18.48, moving -0.65% from the previous trading session.
FLEETCOR (FLT) Announces Plan to Buy UK-Based Global Reach Group
by Zacks Equity Research
The acquisition strengthens FLEETCOR's (FLT) global position as a non-bank cross-border provider of payments by increasing its scale of the same.
Charles River (CRAI) Rides on Business Model, Global Presence
by Zacks Equity Research
Solid international network, business diversification and an excellent professional team boost Charles River (CRAI).
The Zacks Analyst Blog Highlights Cross Country Healthcare, Kforce, RCM Technologies and KornFerry International
by Zacks Equity Research
Cross Country Healthcare, Kforce, RCM Technologies and KornFerry International are part of Zacks top Analyst Blog.
Reasons Why You Should Invest in H&R Block (HRB) Stock Now
by Zacks Equity Research
H&R Block's (HRB) digitalization of its business can be one of the primary drivers of its performance post the pandemic..
4 Staffing Stocks to Watch on Solid Job Additions to Economy
by Ritujay Ghosh
The United States has been adding a record number of jobs, helping staffing stocks Cross Country Healthcare, Inc. (CCRN), Kforce Inc. (KFRC), RCM Technologies, Inc. (RCMT) and KornFerry International (KFY).
Here's Why You Should Retain Omnicom (OMC) in Portfolio Now
by Zacks Equity Research
Omnicom (OMC) rides on solid investor-friendly steps and organic growth initiatives.
Reasons to Retain Insperity (NSP) Stock in Your Portfolio
by Zacks Equity Research
Insperity (NSP) puts consistent efforts to reward shareholders through share repurchases and dividends. Increasing expenses remain a concern.
5 Reasons to Add Gartner (IT) Stock to Your Portfolio Now
by Zacks Equity Research
Gartner's (IT) high-quality, timely, thought-provoking and comprehensive analysis offering helps it counter growing competition.
Here's Why Investors Should Buy ABM Industries (ABM) Now
by Zacks Equity Research
Strategic acquisitions and investor-friendly steps boost ABM Industries (ABM).
Reasons to Retain ICF International (ICFI) in Your Portfolio
by Zacks Equity Research
ICF International, Inc. (ICFI) is seeing solid growth in its service revenues driven by strength in IT modernization and digitization, disaster management and public health services.
The Zacks Analyst Blog Highlights Kforce, Tyler Technologies, IBEX, Cross Country Healthcare, and RCM Technologies.
by Zacks Equity Research
Kforce, Tyler Technologies, IBEX, Cross Country Healthcare, and RCM Technologies are part of Zacks top Analyst Blog.
Accenture (ACN) to Gain From Advocate Buyout: Here's How
by Zacks Equity Research
The latest deal is expected to help Accenture (ACN) expand its technology business management capabilities.
5 Business Services Stocks to Buy on Solid Job Data for May
by Nalak Das
We have narrowed our search to five business services stocks that have solid potential for the rest of 2022. These are: KFRC, IBEX, TYL, CCRN and RCMT.
Does Cross Country (CCRN) Have the Potential to Rally 89% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Cross Country (CCRN) points to an 89.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Accenture (ACN) to Gain From Greenfish Buyout: Here's How
by Zacks Equity Research
The latest deal is expected to strengthen Accenture's (ACN) sustainability services across Europe.